Aims Prostate pathologies Endometriosis Toxemia of Pregnancy

Post on 17-Jan-2018

215 views 0 download

description

Prostate Gland Relatively small through childhood Begins to grow at puberty and maintains a constant size from age 20-50. Around age 50 in some men there is a decrease in testosterone and an involution of the prostate gland. Robbins Basic Pathology 18-10

Transcript of Aims Prostate pathologies Endometriosis Toxemia of Pregnancy

Aims

• Prostate pathologies • Endometriosis• Toxemia of Pregnancy

• Readings; Robbins, Chapters 18 & 19

Prostate Gland

• Relatively small through childhood• Begins to grow at puberty and maintains a

constant size from age 20-50.• Around age 50 in some men there is a decrease

in testosterone and an involution of the prostate gland.

Robbins Basic Pathology 18-10

Benign Prostatic Hyperplasia

• Hyperplasia of prostatic stroma and epithelial cells forming large and discrete nodules.

• Symptoms– Difficulty urinating.– Distention of bladder.– Due to the compression of the urethra.

Benign Prostatic Hyperplasia

• Onset– Common disorder in men over the age of 50.

• 20% of men 40 years old.• 70% of men 60 years old.• 90% of men 70 years old.

Benign Prostatic Hyperplasia

Robbins & Cotran’s Pathologic Basis of Disease 21-32

Pathogenesis

Benign Prostatic Hyperplasia

Robbins & Cotran’s Pathologic Basis of Disease 21-32

• Dihydrotestosterone (DHT) is a metabolite of testosterone and is the ultimate mediator of prostatic growth.

• DHT is synthesized in the prostate stroma cells from testosterone.

• DHT is 10-times more potent in inducing cell division than testosterone.– Binds to the receptor longer.

Pathogenesis

Benign Prostatic Hyperplasia

Robbins & Cotran’s Pathologic Basis of Disease 21-32

• DHT has an ______________________________ function inducing stromal cell growth.

• DHT binds to a nuclear receptor and signals the transcription of growth factors that induce cell division.

Pathogenesis

Benign Prostatic Hyperplasia

Robbins & Cotran’s Pathologic Basis of Disease 21-32

• DHT had a _______________________________ function inducing epithelial cell growth.

• DHT binds to a nuclear receptor and signals the transcription of growth factors that induce cell division.

Benign Prostatic Hyperplasia

Morphology

Robbins Basic Pathology 18-11 7th Ed.

• Not considered a premalignant lesion.• Nodules can be diverse• Nodules which are primarily glandular are

yellow-pink and soft and secrete milky white prostatic fluid.

• Nodules which are primarily fibromuscular are gray, tough, and non-secretory.

Benign Prostatic Hyperplasia

Histology

• Nodules may be due to glandular proliferation, glandular dilation, fibrous stroma proliferation (most prevalent), or muscular stroma proliferation.

• All of these elements are present in each case.

Robbins & Cotran’s Pathologic Basis of Disease 23-19B

Benign Prostatic Hyperplasia

• Treatment– Watchful waiting– Finasteride (Proscar)– Transurethral resection of the prostate

gland (400,000/ year in US)

Prostate Cancer• Symptoms

– Early microscopic cancers are usually asymptomatic.

– Later larger cancers can cause difficulty urinating.

– Metastasis to the bone can cause back pain.

Prostate Cancer

• Onset– Most common form of cancer in men.– Ethnicity is an important factor.

• Asians rarely have this disease.• Caucasian Americans 50-times more likely to have

disease than Asians.• 2-3% of adult male deaths.• Disease of men over the age of 50.• Only 1% of cancers are diagnosed before age 50.

Prostate Cancer

• Factors– Age– Race– Hormone levels (testosterone)– Family history– Environment.

Prostate Cancer

• Pathology– Cancer cell growth usually stimulated by

testosterone.

– Cancer is spread via direct local invasion (seminal vesicles), blood stream (bone), or lymphatics.

Prostate Cancer

• Most common form of ______________________________________.

• Well defined.

Morphology

Robbins & Cotran’s Pathologic Basis of Disease 21-34 6th Ed.

Prostate Cancer• Treatment

– Early localized disease can be treated by surgery and radiation.

– Advanced metastatic disease is treated by endocrine therapy (Lupron).

– Growth can be inhibited by inhibiting the production of testosterone via removal of testes.

– Additionally, estrogen treatment can inhibit production of testosterone.

Endometriosis

• Endometriosis is a painful, chronic disease that affects 5 1/2 million women and girls in the USA and Canada, and millions more worldwide.

• The presence of endometrium in abnormal places including ovaries.– This misplaced tissue develops into growths or lesions which respond

to the menstrual cycle in the same way that the tissue of the uterine lining does: each month the tissue builds up, breaks down, and sheds.

Endometriosis

• Symptoms– Menstrual irregularities.

• Dysmenorrhea– Pelvic pain.

• Due to internal bleeding, breakdown of the blood and tissues, and inflammation

– Infertility (30-40%).

Endometriosis

• Onset

– Disease of women in active reproductive life (most commonly in their 20-30’s).

– Effecting ~10% of women.

EndometriosisMorphology

Robbins Basic Pathology 19-11

• Sectioned ovary revealing large endometriotic cyst.

EndometriosisPathogenesis

Robbins Basic Pathology 19-10

• Regurgitation theory– Retrograde menstruation through the fallopian tubes.

• Metaplastic theory– Endometrium could arise from originating tissue

(coelomic epithelium).

• ___________________________________ theory– Endometrial cells spread via the blood and lymphatics.

Endometriosis

• Genetics– Hormone levels– Acromase cytochrome P450 in endometriotic tissue

can synthesize estrogen.

• Immune factors– Association with allergies.

Endometriosis

• Treatments– Pain mediations– Hormonal therapy

• Hormonal treatment aims to stop ovulation.

– Surgery• Conservative surgery seeks to remove or destroy

the growths. Radical surgery, which may be necessary in severe cases, involves hysterectomy, removal of all growths, and removal of ovaries.

Toxemia of Pregnancy (Preeclampsia and Eclampsia)

• Symptoms– Rapid elevation of blood pressure (hypertension).– Weight gain.– Large amounts of protein in urine (proteinuria).– Excess salt and water retention (edema).– Arterial spasm.

Toxemia of Pregnancy (Preeclampsia and Eclampsia)

• Onset– 4-6% of pregnant women in the last few months of

pregnancy.

Toxemia of Pregnancy (Preeclampsia and Eclampsia)

• Pathology– Hypotheses:

– Excess secretion of adrenal or placental hormones.

– Autoimmune or ___________________________________

Toxemia of Pregnancy (Preeclampsia and Eclampsia)

• 3 Important Events in Pathogenesis• Placental ischemia

– (Abnormality of placentation leads to ischemia.)

• Hypertension– Due to vasoconstriction

• Disseminated intravascular coagulation (DIC)– unregulated thrombin and plasmin generation → widespread

microvascular thrombosis & hemorrhage → ischemia and fibrinolysis → organ damage.

• Without treatment a high percentage of mothers die.

Toxemia of Pregnancy (Preeclampsia and Eclampsia)

Robbins and Cotran’s Pathologic Basis of Disease 22-61

Toxemia of Pregnancy (Preeclampsia and Eclampsia)

• Treatment– Vasodilating drugs– Termination of pregnancy

• Cesarean section.

Next Time

• Neoplasia

• Readings; Robbins, Chapter 6

Objectives

1. Understand the symptoms, onset, histology/ morphology, pathogenesis, & treatment of benign prostatic hyperplasia and prostate cancer.

2. Understand the symptoms, onset, histology/ morphology, pathogenesis, & treatment of endometriosis and toxemia of pregnancy.